TCEs – Talk Bio

Actionable Insights Powered by AI

Candid Therapeutics Expands T-Cell Engager Portfolio with Three New R&D Collaborations

Candid Therapeutics, T-cell engagers (TCEs), autoimmune diseases, R&D collaborations, biotechnology partnerships